Similar articles

• [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].

  Pouget J. Pouget J. Rev Prat. 1994 Nov 15;44(18):2404-6. Rev Prat. 1994. PMID: 7855497 French. No abstract available.
• [Use of intravenous immunoglobulin in neurological disorders].

  Steck AJ. Steck AJ. Rev Med Suisse. 2005 Apr 27;1(17):1167-70. Rev Med Suisse. 2005. PMID: 15941089 Review. French.
• [Peripheral neuropathies: diagnosis and treatment].

  Suárez GA. Suárez GA. Rev Neurol. 1996 Jun;24(130):676-80. Rev Neurol. 1996. PMID: 8653615 Review. Spanish. No abstract available.
• [Treatment of dysimmune neuropathies with intravenous polyvalent human immunoglobulins].

  Leger JM, Hoang-Xuan K, Chennoufi A, Saidi H, Bouche P, Baumann N, Brunet P. Leger JM, et al. Presse Med. 1992 Oct 3;21(32):1533. Presse Med. 1992. PMID: 1334543 French. No abstract available.
• Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy.

  Wijdicks EF, Fulgham JR. Wijdicks EF, et al. Muscle Nerve. 1994 Dec;17(12):1494-5. Muscle Nerve. 1994. PMID: 7969261 No abstract available.